Doximity, Inc.

NYSE:DOCS

41.82 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q3
Revenue 126.676118.057135.284113.612108.469110.966115.262102.18590.63993.65397.87679.3572.66966.68758.70945.11336.38836.35432.426
Cost of Revenue 13.5512.56712.1912.75913.15313.67713.52613.2113.07711.76511.0858.9517.9867.9937.8727.4567.8754.2813.78
Gross Profit 113.126105.49123.094100.85395.31697.289101.73688.97577.56281.88886.79170.39964.68358.69450.83737.65728.51332.07328.646
Gross Profit Ratio 0.8930.8940.910.8880.8790.8770.8830.8710.8560.8740.8870.8870.890.880.8660.8350.7840.8820.883
Reseach & Development Expenses 22.57420.14819.94619.95821.93121.54120.51919.10419.02217.42416.22515.4613.24112.55811.4069.86610.0438.8918.605
General & Administrative Expenses 9.2559.9739.6418.9669.2479.7599.5138.7498.72410.6449.0798.8277.1965.7034.4783.2093.1021.7681.954
Selling & Marketing Expenses 35.24433.51734.95630.20134.45533.14833.2229.02128.13425.89925.69821.16119.37117.58617.01714.14513.28510.35210.669
SG&A 44.29743.4944.59739.16743.70242.90742.73337.7736.85836.54334.77729.98826.56723.28921.49517.35416.38712.1212.623
Other Expenses -0.0520.073-0.0555.9034.8393.8752.4610.9080.804-0.0160.02-0.02-0.031-0.2634.601-0.093-0.2900
Operating Expenses 66.87163.63864.54359.12565.63364.44863.25256.87455.8853.96751.00245.44839.80835.84732.90127.2226.4322.21721.265
Operating Income 46.25541.85258.55133.79229.68332.84138.48432.10121.68227.92135.78924.95124.87522.84717.93610.4372.08311.0627.418
Operating Income Ratio 0.3650.3550.4330.2970.2740.2960.3340.3140.2390.2980.3660.3140.3420.3430.3060.2310.0570.3040.229
Total Other Income Expenses Net 6.9146.101-0.315-2.0334.8393.8752.4610.9080.804-0.0160.02-0.02-0.031-0.2634.601-0.093-0.29-0.8860.325
Income Before Tax 53.16947.95363.03239.69534.52236.71640.94533.00922.48627.90535.80925.37124.9222.88522.53710.4171.9310.1767.743
Income Before Tax Ratio 0.420.4060.4660.3490.3180.3310.3550.3230.2480.2980.3660.320.3430.3430.3840.2310.0530.280.239
Income Tax Expense 11.7927.33515.0769.0936.1166.0487.4776.710.103-8.821-19.838-10.717-1.4021.4025.3060.380.4712.7071.84
Net Income 41.37740.61847.95630.60228.40630.66833.46826.29922.38336.72655.64736.08826.32221.48317.23110.0371.4593.5145.903
Net Income Ratio 0.3270.3440.3540.2690.2620.2760.290.2570.2470.3920.5690.4550.3620.3220.2930.2220.040.0970.182
EPS 0.220.220.260.160.150.160.170.120.120.170.30.190.120.250.0360.0110.010.0450.072
EPS Diluted 0.210.20.240.150.130.140.160.120.10.170.260.170.090.190.0320.010.010.0430.072
EBITDA 48.81744.461.3252.26832.28735.54941.134.6924.05229.28937.1526.10926.02823.83818.95111.3652.85111.3647.617
EBITDA Ratio 0.3850.3760.4530.460.2980.320.3570.3390.2650.3130.380.3290.3580.3570.3230.2520.0780.3130.235